Table 4.
LCH diagnosis and occurrence of AM in different groups of age.
| LCH during childhood and AM during adulthood | ||
|---|---|---|
| Associated Malignancy | N | Interval (years) of AM occurrence after LCH diagnosis |
| AML | 2 | |
| FAB M2 | 1 | 25 |
| FAB M5 | 1 | 14 |
| Lymphomas | 2 | |
| Hodgkin | 1 | 7 |
| Non-Hodgkin | 1 | 20 |
| Solid tumors | 13 | |
| Bone | 2 | 11; 22 |
| Breast | 1 | 27 |
| CNS | 3 | 13; 21; 13 |
| Liver | 2 | 18; 19 |
| Lung | 1 | 14 |
| Thyroid | 1 | 17 |
| Skin | 3 | 12; 25; 36 |
| LCH during adulthood and AM during childhood | ||
| Associated Malignancy | N | Interval (years) of AM occurrence before LCH diagnosis |
| Lymphomas | 2 | |
| Hodgkin | 2 | -7; -6 |